PTPRA facilitates cancer growth and migration via the TNF-α-mediated PTPRA-NF-κB pathway in MCF-7 breast cancer cells.

Abstract:

:Protein tyrosine phosphatase receptor type A (PTPRA), one of the classic protein tyrosine phosphatases, is crucial for modulating tumorigenesis and metastasis in breast cancer; however, its functional mechanism has not fully elucidated. The present study assessed PTPRA expression and estimated its clinical impact on survival using the Gene Expression Profiling Interactive Analysis database (GEPIA). Growth curves, colony formations and Transwell assays were utilized to examine cell proliferation and migration. Additionally, luciferase reporter assays were used to examine the potential tumor signaling pathways targeted by PTPRA in HEK293T cells. Furthermore, quantitative PCR (qPCR) was utilized to confirm the transcriptional regulation of PTPRA expression. Bioinformatic analyses of data from GEPIA identified PTPRA overexpression in patients with breast cancer. The growth curve, colony formation and transwell experiments demonstrated that PTPRA upregulation significantly promoted the cell proliferation and migration of MCF-7 breast cancer cells. In contrast, PTPRA knockdown significantly attenuated cell proliferation and migration. Mechanistic experiments revealed that the transcriptional activity of NF-κB was higher compared with other classic tumor pathways when they were activated by PTPRA in HEK293T cells. Furthermore, the transcriptional activity of NF-κB was altered in a PTPRA-dose-dependent manner. Additionally, following exposure to TNF-α, PTPRA-deficient MCF-7 cells exhibited lower NF-κB transcriptional activity compared with normal control cells. The results of the present study demonstrate that PTPRA overexpression accelerates inflammatory tumor phenotypes in breast cancer and that the TNF-α-mediated PTPRA-NF-κB pathway may offer novel insight into early diagnosis and optimum treatment for breast cancer.

journal_name

Oncol Lett

journal_title

Oncology letters

authors

Lin C,Xin S,Huang X,Zhang F

doi

10.3892/ol.2020.11992

subject

Has Abstract

pub_date

2020-11-01 00:00:00

pages

131

issue

5

eissn

1792-1074

issn

1792-1082

pii

OL-0-0-11992

journal_volume

20

pub_type

杂志文章
  • Expression of septin 2 and association with clinicopathological parameters in colorectal cancer.

    abstract::Septin 2 (SEPT2) is a tumor-related gene belonging to the SEPT family that affects the cellular processes of hepatoma carcinoma cells, glioblastoma cells and mesangial cells and is highly expressed in breast cancer, biliary tract cancer and acute myeloid leukemia. Colorectal cancer (CRC) is the third most common type ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2019.10528

    authors: He H,Li J,Xu M,Kan Z,Gao Y,Yuan C

    更新日期:2019-09-01 00:00:00

  • Thyroid transcription factor 1 and p63 expression is associated with survival outcome in patients with non-small cell lung cancer treated with erlotinib.

    abstract::While erlotinib is primarily administered to patients with non-small cell lung cancer with sensitizing epidermal growth factor receptor (EGFR) mutations, it is also prescribed to patients with wild type (wt) EGFR in higher lines of treatment. However, there is no predictive marker for erlotinib efficacy in patients wi...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2020.11663

    authors: Svaton M,Fiala O,Krakorova G,Blazek J,Hurdalkova K,Barinova M,Mukensnabl P,Pesek M

    更新日期:2020-08-01 00:00:00

  • Molecular pathways associated with transcriptional alterations in hyperparathyroidism.

    abstract::Hyperparathyroidism is characterized by the oversecretion of parathyroid hormone biochemically and increased cell proliferation histologically. Primary and secondary hyperparathyroidism exhibit distinct pathophysiology but share certain common microscopic features. The present study performed the first genome-wide exp...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2016.4623

    authors: Lee F,Lee JJ,Jan WC,Wu CJ,Chen HH,Cheng SP

    更新日期:2016-07-01 00:00:00

  • Notable roles of EZH2 and DNMT1 in epigenetic dormancy of the SHP1 gene during the progression of chronic myeloid leukaemia.

    abstract::Tumor development is associated with the methylation of cytosine-guanine (CpG) islands. The occurrence of methylation requires several factors, such as DNA methylation systems and polycomb group (PcG) proteins. At present, novel drugs are needed for the treatment of chronic myeloid leukaemia (CML), particularly consid...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.6050

    authors: Wang J,Hua L,Guo M,Yang L,Liu X,Li Y,Shang X,Luo J

    更新日期:2017-06-01 00:00:00

  • ATF3 suppresses ESCC via downregulation of ID1.

    abstract::Esophageal cancer is one of the most prevalent forms of cancer and has a particularly high mortality rate due to early metastasis; however, the underlying mechanisms of its formation and progression remain unclear. The present study performed immunohistochemical analysis and observed that the expression of activating ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2016.4832

    authors: Li J,Yang Z,Chen Z,Bao Y,Zhang H,Fang X,Yang W

    更新日期:2016-09-01 00:00:00

  • Transcriptional co-activator with PDZ-binding motif overexpression promotes cell proliferation and transcriptional co-activator with PDZ-binding motif deficiency induces cell cycle arrest in neuroblastoma.

    abstract::Transcriptional co-activator with PDZ-binding motif (TAZ) is a transcriptional co-activator which binds to a variety of transcription factors. An increasing number of studies have provided evidence that TAZ may be a positive regulator of cell proliferation and tumorigenesis. To reveal the underlying mechanisms by whic...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.6030

    authors: Yang L,Huang M,Tan J,Hou J,He J,Wang F,Cui H,Yi L

    更新日期:2017-06-01 00:00:00

  • Damnacanthal is a potent inducer of apoptosis with anticancer activity by stimulating p53 and p21 genes in MCF-7 breast cancer cells.

    abstract::Damnacanthal, an anthraquinone compound, is isolated from the roots of Morinda citrifolia L. (noni), which has been used for traditional therapy in several chronic diseases, including cancer. Although noni has long been consumed in Asian and Polynesian countries, the molecular mechanisms by which it exerts several ben...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2014.1898

    authors: Aziz MY,Omar AR,Subramani T,Yeap SK,Ho WY,Ismail NH,Ahmad S,Alitheen NB

    更新日期:2014-05-01 00:00:00

  • CD44v6 may influence ovarian cancer cell invasion and migration by regulating the NF-κB pathway.

    abstract::Ovarian cancer (OC) has the worst prognosis among all malignancy types in females worldwide according to epidemiological studies in 2017. Although radiotherapy, chemotherapy and surgical treatment are the most common treatment methods, their curative effects are not satisfactory. The present study aimed to examine the...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2019.10306

    authors: Wang Y,Yang X,Xian S,Zhang L,Cheng Y

    更新日期:2019-07-01 00:00:00

  • Polydatin inhibits hepatocellular carcinoma via the AKT/STAT3-FOXO1 signaling pathway.

    abstract::Polydatin, extracted from Polygonum cuspidatum, is known for its anti-platelet aggregation and anti-inflammatory effects. However, studies on the association of polydatin with cancer are limited, particularly with regards to epithelial-mesenchymal transition (EMT)-associated migration and invasion of cancer cells. The...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2019.10123

    authors: Jiang J,Chen Y,Dong T,Yue M,Zhang Y,An T,Zhang J,Liu P,Yang X

    更新日期:2019-05-01 00:00:00

  • Screening of potential therapy targets for prostate cancer using integrated analysis of two gene expression profiles.

    abstract::The aim of the present study was to analyze potential therapy targets for prostate cancer using integrated analysis of two gene expression profiles. First, gene expression profiles GSE38241 and GSE3933 were downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) between prostate can...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.6879

    authors: Zhao R,Wang Y,Zhang M,Gu X,Wang W,Tan J,Wei X,Jin N

    更新日期:2017-11-01 00:00:00

  • lncRNA-CD160 decreases the immunity of CD8+ T cells through epigenetic mechanisms in hepatitis B virus infection.

    abstract::The transfer and development of chronic hepatitis B virus (HBV) infection is associated with the T cell immune response, therefore investigating the key regulators of cell immune response is needed to improve chronic HBV treatment. Blood samples from patients with chronic HBV infection were used to confirm the correla...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2020.11534

    authors: Wu J,Niu Q,Yuan J,Xu X,Cao L

    更新日期:2020-07-01 00:00:00

  • Anaplastic thyroid carcinoma with diffuse thoracic skin metastasis: A case report.

    abstract::Anaplastic thyroid carcinoma is a significantly fatal endocrine neoplasm, with an average survival time of 4-12 months following diagnosis. The present study reports the case of a 57-year-old male patient who presented to the Bağcılar Training and Research Hospital (Istanbul, Turkey) due to swelling in the neck and di...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2014.2036

    authors: Altinay S,Taş B,Ozen A,Süt PA

    更新日期:2014-06-01 00:00:00

  • Inhibition of lysine-specific demethylase 1 prevents proliferation and mediates cisplatin sensitivity in ovarian cancer cells.

    abstract::Lysine-specific demethylase 1 (LSD1) functions as a transcriptional coregulator by modulating histone methylation and has been associated with numerous high-risk cancers. Previously, our group and others identified LSD1 as an upregulated gene in ovarian cancer, and reported that the upregulation of LSD1 was associated...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.8511

    authors: Shao G,Wan X,Lai W,Wu C,Jin J,Liu X,Wei Y,Lin Q,Zhang L,Shao Q

    更新日期:2018-06-01 00:00:00

  • Long non-coding RNA RP11-480I12.5 promotes cervical carcinoma progression by regulating the Wnt/β-catenin signaling pathway.

    abstract::The long non-coding RNA (lncRNA), RP11-480I12.5 is one of the most dysregulated lncRNAs, which is believed to contribute to the progression of cervical carcinoma (CC); however, the exact function of RP11-480I12.5 in human CC remains unknown. The present study aimed to investigate the function and underlying molecular ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2019.11120

    authors: Zhang L,Li Y,Sona L

    更新日期:2020-01-01 00:00:00

  • Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer.

    abstract::Human papillomavirus (HPV) is widely known as a cause of cervical intraepithelial neoplasia (CIN) and cervical cancer. The mechanisms involved have been studied by numerous studies. The integration of the virus genome into the host cells results in the abnormal regulation of cell cycle control. HPV can also induce imm...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2015.3295

    authors: Song D,Li H,Li H,Dai J

    更新日期:2015-08-01 00:00:00

  • Significance and prognosis of epithelial-cadherin expression in invasive breast carcinoma.

    abstract::The objective of the present study was to investigate and analyze the epithelial-cadherin (E-cadherin) expression in invasive ductal carcinoma of the breast, and to analyze the associations between the expression and clinicopathological characteristics of lymph node metastasis and the prognosis of breast cancer. The i...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.8836

    authors: Yang L,Wang XW,Zhu LP,Wang HL,Wang B,Zhao Q,Wang XY

    更新日期:2018-08-01 00:00:00

  • Antitumor effects of dioscin in A431 cells via adjusting ATM/p53-mediated cell apoptosis, DNA damage and migration.

    abstract::Skin cancer is the deadliest type of malignant disease and causes primary mortality worldwide. Dioscin, which exists in medicinal plants, has potent anticancer effects. However, its effects on skin cancer remain unknown. In the present study, the activity and mechanism of dioscin on the human skin cancer A431 cell lin...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2020.12321

    authors: Wang P,Wang C,Liu C

    更新日期:2021-01-01 00:00:00

  • DR2 blocker thioridazine: A promising drug for ovarian cancer therapy.

    abstract::Dopamine receptor 2 (DR2) may be a biomarker for various types of cancer. Ovarian cancer cells overexpress DR2; therefore, blocking DR2 may be a novel treatment strategy for ovarian cancer. Thioridazine, a DR2 blocker, has antineoplastic activity in a variety of cancer cells. In view of the requirement for novel thera...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.7184

    authors: Yong M,Yu T,Tian S,Liu S,Xu J,Hu J,Hu L

    更新日期:2017-12-01 00:00:00

  • The heterogenic tumor microenvironment of hepatocellular carcinoma and prognostic analysis based on tumor neo-vessels, macrophages and α-SMA.

    abstract::The present study was performed to quantify tumor neo-vessels, macrophages and fibroblasts in the tumor microenvironment of hepatocellular carcinoma (HCC) and explore the prognostic factors of HCC. The distribution of tumor neo-vessels, macrophages and fibroblasts was quantified by immunohistochemistry and inverted mi...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.7946

    authors: Fang M,Yuan J,Chen M,Sun Z,Liu L,Cheng G,Ying H,Yang S,Chen M

    更新日期:2018-04-01 00:00:00

  • Activating transcription factor 2 expression mediates cell proliferation and is associated with poor prognosis in human non-small cell lung carcinoma.

    abstract::Activating transcription factor 2 (ATF2) is a member of the cAMP response element binding protein family that heterodimerizes and activates other transcription factors involved in stress and DNA damage responses, growth, differentiation and apoptosis. ATF2 has been investigated as a potential carcinogenic biomarker in...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2015.3922

    authors: You Z,Zhou Y,Guo Y,Chen W,Chen S,Wang X

    更新日期:2016-01-01 00:00:00

  • Anillin is a prognostic factor and is correlated with genovariation in pancreatic cancer based on databases analysis.

    abstract::Pancreatic cancer has a low survival rate globally. Anillin (ANLN) is involved in the pathogenesis of pancreatic cancer (PC). The present study used databases and reverse transcription-quantitative PCR to investigate the association between ANLN expression, clinical variables and the survival rate of patients with pan...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2020.12368

    authors: Nie Y,Zhao Z,Chen M,Ma F,Fan Y,Kang Y,Kang B,Wang C

    更新日期:2021-02-01 00:00:00

  • Reduced expression levels of PTEN are associated with decreased sensitivity of HCC827 cells to icotinib.

    abstract::The clinical resistance of non-small cell lung cancer (NSCLC) to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) has been linked to EGFR T790M resistance mutations or MET amplifications. Additional mechanisms underlying EGFR-TKI drug resistance remain unclear. The present study demonstrated t...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.5829

    authors: Zhai Y,Zhang Y,Nan K,Liang X

    更新日期:2017-05-01 00:00:00

  • Downregulation of miR-544 in tissue, but not in serum, is a novel biomarker of malignant transformation in glioma.

    abstract::Low-grade glioma is predisposed to progress to anaplastic astrocytoma and eventually secondary glioblastoma. The malignant transformation may involve the accumulation of multiple genetic alterations. The purpose of this study was to explore the role of miR-544 in glioma progression and discuss whether it may be a nove...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2012.918

    authors: Ma R,Zhang G,Wang H,Lv H,Fang F,Kang X

    更新日期:2012-12-01 00:00:00

  • Telomeres and telomerase in oncogenesis.

    abstract::Telomeres are located at the ends of chromosomes and protect them from degradation. Suppressing the activity of telomerase, a telomere-synthesizing enzyme, and maintaining short telomeres is a protective mechanism against cancer in humans. In most human somatic cells, the expression of telomerase reverse transcriptase...

    journal_title:Oncology letters

    pub_type: 杂志文章,评审

    doi:10.3892/ol.2020.11659

    authors: Trybek T,Kowalik A,Góźdź S,Kowalska A

    更新日期:2020-08-01 00:00:00

  • PARP9 is overexpressed in human breast cancer and promotes cancer cell migration.

    abstract::Poly(ADP-Ribose) polymerase family member 9 (PARP9) promotes the proliferation, survival and chemotherapy resistance in lymphoma and prostate cancer. The expression and function of PARP9 in human breast cancer remains unknown. In the present study, it was demonstrated that PARP9 is frequently overexpressed in human br...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.9124

    authors: Tang X,Zhang H,Long Y,Hua H,Jiang Y,Jing J

    更新日期:2018-09-01 00:00:00

  • Novel association of MEN1 gene mutations with parathyroid carcinoma.

    abstract::Inactivating mutations of the multiple endocrine neoplasia 1 (MEN1) gene cause MEN1 syndrome, characterized by primary hyperparathyroidism (pHPT), and parathyroid and gastro-entero-pancreatic pituitary tumors. At present, only 14 cases of malignant parathyroid tumor have been associated with the syndrome, with 6 cases...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.6162

    authors: Cinque L,Sparaneo A,Cetani F,Coco M,Clemente C,Chetta M,Balsamo T,Battista C,Sanpaolo E,Pardi E,D'Agruma L,Marcocci C,Maiello E,Hendy GN,Cole DEC,Scillitani A,Guarnieri V

    更新日期:2017-07-01 00:00:00

  • RNA sequencing uncovers the key long non-coding RNAs and potential molecular mechanism contributing to XAV939-mediated inhibition of non-small cell lung cancer.

    abstract::The present study aimed to reveal the key long non-coding RNAs (lncRNAs) and the potential molecular mechanisms of XAV939 treatment in non-small cell lung cancer (NSCLC). The NSCLC cell line, NCI-H1299, was cultured with 10 µM XAV939 for 12 h, and NCI-H1299 cells without XAV939 treatment were used as controls. Followi...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2019.10191

    authors: Yu H,Han Z,Xu Z,An C,Xu L,Xin H

    更新日期:2019-06-01 00:00:00

  • Restoration of microRNA-130b expression suppresses osteosarcoma cell malignant behavior in vitro.

    abstract::The alteration of microRNA (miR)-130b expression has been associated with promoting or suppressing numerous types of human cancer. A previous study evaluated the expression level of miR-130b in osteosarcoma tissues, and subsequently investigated the effects of miR-130b on the regulation of osteosarcoma cells malignant...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.8643

    authors: Wu Y,Sun W,Kong Y,Liu B,Zeng M,Wang W

    更新日期:2018-07-01 00:00:00

  • Apigenin inhibits growth and induces apoptosis in human cholangiocarcinoma cells.

    abstract::A promising nutraceutical, apigenin, was recently revealed to exhibit biological activity in inhibiting several types of cancer. The effects of apigenin on the growth inhibition and apoptosis of the cholangiocarcinoma HuCCA-1 cell line were investigated. Protein alterations subsequent to apigenin treatment were studie...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.6705

    authors: Subhasitanont P,Chokchaichamnankit D,Chiablaem K,Keeratichamroen S,Ngiwsara L,Paricharttanakul NM,Lirdprapamongkol K,Weeraphan C,Svasti J,Srisomsap C

    更新日期:2017-10-01 00:00:00

  • Clinicopathological characteristics of pulmonary epithelioid hemangioendothelioma: A report of four cases and review of the literature.

    abstract::This study aimed to investigate the clinicopathological characteristics, differential diagnosis and prognosis of pulmonary epithelioid hemangioendothelioma (PEH). PEH is a rare low-grade malignant vascular tumor. The cause of PEH remains unclear. Patient prognosis is unpredictable, with life expectancy ranging from 1 ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2014.2566

    authors: Shao J,Zhang J

    更新日期:2014-12-01 00:00:00